# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $335 price target.
Deutsche Bank analyst Pito Chickering maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $359 t...
JP Morgan analyst Lisa Gill maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $327 to $332.